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Abstract: Actinoporins are α-pore forming proteins with therapeutic potential, produced 
by sea anemones. Sticholysin II (StnII) from Stichodactyla helianthus is one of its most 
extensively characterized members. These proteins remain stably folded in water, but upon 
interaction with lipid bilayers, they oligomerize to form a pore. This event is triggered by 
the presence of sphingomyelin (SM), but cholesterol (Chol) facilitates pore formation. 
Membrane attachment and pore formation require changes involving long-distance 
rearrangements of residues located at the protein-membrane interface. The influence of 
Chol on membrane recognition, oligomerization, and/or pore formation is now studied 
using StnII variants, which are characterized in terms of their ability to interact with model 
membranes in the presence or absence of Chol. The results obtained frame Chol not only 
as an important partner for SM for functional membrane recognition but also as a molecule 
which significantly reduces the structural requirements for the mentioned conformational 
rearrangements to occur. However, given that the DOPC:SM:Chol vesicles employed 
display phase coexistence and have domain boundaries, the observed effects could be also 
due to the presence of these different phases on the membrane. In addition, it is also shown 
that the Arg51 guanidinium group is strictly required for membrane recognition, 
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independently of the presence of Chol. 
Keywords: actinoporin; equinatoxin; sphingomyelin; pore-forming toxin; sphingomyelin 
 
1. Introduction 
Sea anemones are a group of benthic marine animals which secrete various toxins [1] including a group 
of small and basic α-pore forming proteins known as actinoporins [2]. These actinoporins form  
cation-selective pores on the cell membranes, causing colloid-osmotic shock that leads to cells death [3–5]. 
They are believed to participate in anemone functions such as predation, defense, and digestion, and 
have been shown to be lethal to small crustaceans, mollusks, fish [6], and parasites [7]. All known 
actinoporins display high sequence identity and appear as multigene families [8,9]. However, only four 
of them have been characterized in deep detail: Equinatoxin II (EqtII) from Actinia equina [8], 
Sticholysins I and II (StnI and StnII) from Stichodactyla helianthus [10,11], and Fragaceatoxin C (Fra C) 
from Actinia fragacea [12]. Like many other marine toxins, actinoporins show some therapeutic 
potential, including different pharmacological effects, presumable anticancer activities, and use in the 
construction of specific immunotoxins [1,7,13–18]. 
In addition to their potential as therapeutic drugs, actinoporins have gained remarkable attention 
because they show a singular behavior at the water–lipid membrane interface. In aqueous solution they 
remain stably folded, but they become integral membrane structures upon interaction with lipid 
bilayers, oligomerizing to form pores [10,11,19]. It is widely accepted that the bilayers targeted must 
contain sphingomyelin (SM) and/or display phase coexistence [20–25]. In fact, the effect of not  
only SM but also Chol on the membrane pore-forming ability of StnII has been thoroughly  
studied [21,22,25–29]. According to those results, it is now quite clear that the presence of Chol eases 
the formation of pores by StnII, a conclusion which is in agreement with the coexistence of Chol and 
SM in biological membranes [27,30–33]. However, what still remains poorly studied is the nature of 
the protein determinants which explain this effect. To answer this question, we have studied a battery 
of different StnII mutants affecting different protein regions presumably involved in pore formation. 
The water-soluble structure of StnII is known in detail [34]. It folds as a β-sandwich motif 
composed of 10 β-strands flanked by two α-helices which interact with both sides of the β-sandwich 
(Figure 1). One of these helices (α1) is located near the N-terminal end. In fact, the first 30 residues 
appear to be able to adopt alternative conformations without disrupting the fold of the β-sandwich [35]. 
This feature, altogether with the amphipathic character of this stretch, seems to be extremely important 
for the final functionality of the pore, since the α1 helix has been proposed to extend and further insert 
into the membrane to form the pore walls [17,36,37]. The most recent model explaining the 
mechanism of actinoporins’ pore formation [17,37–39] assumes a toroidal protein-lipid structure without 
a well-defined fixed stoichiometry [17,38–40], although an alternative model has been proposed for 
Fra C [41]. Nevertheless, it is reasonably well-proven that insertion of the N-terminus into the 
membrane takes place in anon-coordinate way, shortly after the binding of the toxin and before their 
oligomerization into the final pore [37]. In addition to this N-terminal α-helix, three more regions of 
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the structure seem to be especially important from a functional point of view: a phosphocholine (POC) 
binding site, a cluster of aromatic residues, and an array of basic amino acids [11]. 
 
Figure 1. Diagram of the three-dimensional structure of StnII indicating the location of the 
eight mutated positions: Ala10, Arg29, Arg51, Phe106, Tyr111, Tyr135, Tyr136, and 
Gly142. The different elements of ordered secondary structure, as well as the N- and  
C-terminal ends, are also indicated. The dotted line is a representation of the membrane 
surface. The diagram was constructed from the atomic coordinates deposited to the PDB 
(Protein Data Bank, reference 1GWY for StnII). The image was generated by the MolMol 
Program [67]. 
The work presented here studies the effect of Chol on the membrane-interacting behavior of eight 
different StnII mutants affecting the stretch of the 30 first residues (A10P and R29Q),  
the aromatic cluster (F106L, Y111N, Y135F, and Y136F), the POC binding site (R51Q, Y111N,  
Y135F, and Y136F), and a residue involved in maintaining the pore-competent state of protein 
oligomerization (G142A). 
2. Results 
2.1. Protein Purification and Characterization 
All proteins used in the study were purified to homogeneity according to their behavior in SDS-PAGE. 
Their amino acid compositions were consistent with the introduced mutations. The calculated E0.1%  
(280 nm, 1 cm) values were also in good agreement with the amino acid changes made (Table 1). All 
far-UV CD spectra of the individual mutants were indistinguishable from that corresponding to the 
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wild-type StnII (data not shown). In summary, all eight mutants retained the overall native  
water-soluble conformation. 
The hemolytic activity was diminished in all the mutants studied (Table 1). This may not be a 
surprise, given that all the residues changed are presumably involved in essential steps for the 
formation of the final functional pore [10,11,37]. This effect was especially evident for mutants R29Q, 
Y111N, and G142A (Table 1) [29,42,43]. 
Stability analyses also revealed the importance of some of these residues (Arg29 and Gly142) in 
maintaining the protein conformation as deduced from the large decrease of the Tm values for R29Q 
and G142A mutant variants (Table 1). It is also remarkable that substitution of Tyr111 by Asn and 
Tyr136 by Phe produced mutant proteins with higher Tm values (Table 1). All mutants studied showed 
values high above the temperatures used along the study and, therefore, the results described below 
should not be attributed to thermal denaturing effects. 
Table 1. Structural and functional parameters of the proteins used in the study. 
StnII Variant E0.1% (280 nm, 1 cm) Tm (°C) Relative Hemolytic Activity c 
Wild-type 2.54 a 67 a 1.00 
A10P 2.69 a 66 a 0.26 a 
R29Q 2.54 a 60 a <0.10 a 
R51Q 2.38 67 0.30 
F106L 2.62 a 66 a 0.39 a 
Y111N 2.58 a 70 a <0.10 a 
Y135F 2.47 66 0.26 
Y136F 2.66 69 0.26 
G142A 2.30 b 61 b 0.13 b 
a [29]; b [43]; c Relative hemolytic activity calculated as HC50(WT)/HC50(mut). 
2.2. Protein Binding to the Two Different Lipid Model Vesicles Employed 
ITC was used to measure the interaction of the StnII mutants with DOPC:SM:Chol (1:1:1) or 
POPC:PSM (4:1) vesicles (Figures 2 and 3). The interaction of wild-type StnII with POPC:PSM (4:1) 
vesicles in the presence of low amounts of Chol has been recently described [27]. In the present work 
DOPC:SM:Chol (1:1:1) vesicles were chosen because they are considered a model of coexistence 
between liquid-disordered and liquid-ordered phases [31,44–46]. All mutants studied were observed to 
bind to the DOPC:SM:Chol (1:1:1) vesicles (Figure 2) although with evident differences in terms of 
relative membrane binding affinity values (Table 2). Thus, while A10P still bound with almost 
identical affinity to the wild-type StnII, and F106L showed only a reduction of about 2.5-fold 
(Table 2), all the other mutants displayed values about one to two orders of magnitude smaller. The 
most dramatic differences in affinity were observed for the R29Q, R51Q, Y111N, and Y135F mutants 
(Table 2). Binding to the POPC:PSM (4:1) vesicles was about 100-fold lower than to the  
Chol-containing ones for wild-type StnII (Table 2) and most of the mutants did not produce a 
detectable signal in these experiments (Figure 3). Only binding of the A10P protein variant was 
measurable, showing again a very similar relative binding affinity to the wild-type protein (Table 2). 
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Figure 2. Binding of StnII and its mutants to DOPC:SM:Chol (1:1:1) 100-nm-diameter 
vesicles studied by ITC. Reactant concentrations were as follows: WT (P0 = 1.2 μM,  
L0 = 0.56 mM), A10P (P0 = 1.1 μM, L0 = 0.55 mM), R29Q (P0 = 2.3 μM, L0 = 1.8 mM), 
R51Q (P0 = 10.4 μM, L0 = 3.6 mM), F106L (P0 = 1.1 μM, L0 = 0.53 mM), Y111N 
(P0 = 1.2 μM, L0 = 1.6 mM), Y135F (P0 = 10.4 μM, L0 = 3.4 mM), Y136F (P0 = 1.0 μM, 
L0 = 0.25 mM), and G142A (P0 = 1.2 μM, L0 = 0.25 mM). Binding isotherms were 
adjusted to a model in which protein membrane binding involves the participation of “n” 
lipid molecules. The c values (c = K × P0) for all the graphs are in the range 1–1000. 
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Figure 3. Binding of StnII and its mutants to POPC:PSM (4:1) 100-nm-diameter vesicles 
studied by ITC. Reactant concentrations were as follows: WT (P0 = 10.0 μM, 
L0 =5.4 mM), A10P (P0 = 8.0 μM, L0 = 5.4 mM), R29Q (P0 = 9.9 μM, L0 = 4.8 mM), 
R51Q (P0 = 10.5 μM, L0 = 6.3 mM), F106L (P0 = 9.1 μM, L0 = 4.9 mM), Y111N 
(P0 = 10.1 μM, L0 = 5.1 mM), Y135F (P0 = 10.3 μM, L0 = 3.7 mM), Y136F (P0 = 9.6 μM, 
L0 = 5.1 mM), and G142A (P0 = 9.4 μM, L0 = 5.0 mM). Binding isotherms were adjusted 
to a model in which protein membrane binding involves the participation of “n” lipid 
molecules. Given the low affinity of most of the mutants for the vesicles assayed, in this 
case only the c values (c = K × P0) for WT and A10P are in the range 1–1000. 
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Table 2. Binding of StnII protein variants to DOPC:SM:Chol (1:1:1) and POPC:PSM (4:1) 
vesicles studied by ITC. The interaction of some mutants with POPC:PSM (4:1) vesicles 
was too weak to be detected by ITC in the conditions used for these experiments (see Figure 3) 
(data not shown in the Table). 
DOPC:SM:Chol (1:1:1) 
StnII Variant n K × 10−8 (M−1) ΔG (kcal/mol) ΔH (kcal/mol) ΔS (cal·mol−1·K−1) Relative 
Membranebinding a 
WT 39 ± 4 b 1.700 ± 0.900 b −9.1 ± 0.5 b −44.0 ± 3.0 b −115.0 ± 9.0 b 1.000 b 
A10P 37 ± 4 b 1.900 ± 0.900 b −9.3 ± 0.4 b −39.0 ± 6.0 b −99.0 ± 20.0 b 1.180 b 
R29Q 51 ± 8 b 0.031 ± 0.002 b −6.7 ± 0.2 b −45.0 ± 3.0 b −129.0 ± 8.0 b 0.014 b 
R51Q 49 ± 2 0.140 ± 0.070 −7.6 ± 0.2 −29.0 ± 1.0 −72.0 ± 4.0 0.082 
F106L 36 ± 3 b 0.600 ± 0.100 b −8.6 ± 0.1 b −37.0 ± 7.0 b −94.0 ± 24.0 b 0.380 b 
Y111N 46 ± 7 b 0.025 ± 0.004 b −6.6 ± 0.1 b −47.0 ± 2.0 b −134.0 ± 4.0 b 0.012 b 
Y135F 51 ± 2 0.039 ± 0.013 −6.8 ± 0.2 −36.0 ± 2.0 −99.0 ± 6.0 0.023 
Y136F 40 ± 1 0.270 ± 0.080 −8.1 ± 0.1 −43.0 ± 1.0 −117.0 ± 4.0 0.160 
G142A 32 ± 1 0.250 ± 0.100 −8.2 ± 0.1 −33.0 ± 1.0 −83.0 ± 4.0 0.150 
POPC:PSM (4:1) 
WT 45 ± 2 1.5 ± 0.3 −6.3 ± 0.1 −23.0 ± 1.0 −57.0 ± 3.0 1.000 
A10P 44 ± 3 1.2 ± 0.4 −6.2 ± 0.2 −20.0 ± 2.0 −48.0 ± 6.0 0.800 
a [n(WT) × K(mut)]/[n(mut) × K(WT)] as explained in [29]; b [29]. 
2.3. Pore Formation 
Pore formation was monitored by recording the fluorescence emission of calcein released from lipid 
model vesicles. These vesicles are only a simplified version of a real membrane. This would explain 
why, in general, actinoporins seem to be more effective against erythrocytes. However, this approach 
is extremely useful because it allows the determination of different biophysical parameters and, most 
of all, the dissection of the individual roles of different types of lipid molecules, as is the case in this 
work. Within this idea, wild-type StnII and the A10P, F106L, Y136F, and G142A variants displayed an 
indistinguishable kinetic of calcein release from DOPC:SM:Chol (1:1:1) vesicles (Figure 4A). The R29Q 
and Y135F mutants were able to induce calcein leakage but exhibited a largely decreased velocity 
constant. The R51Q and Y111N mutants, on the other hand, were unable to release the entrapped 
fluorophore (Figure 4). 
For POPC:PSM (4:1) vesicles, only the A10P mutant variant was able to induce calcein release, 
although to a lower extent than the wild-type protein (Figure 4B). This would be explained by the 
conformational stiffness introduced in this StnII mutant by the substitution of an Ala residue by Pro 
that would hamper pore formation without loss of binding affinity [29]. 
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Figure 4. Release of calcein entrapped in DOPC:SM:Chol (1:1:1) (A) or POPC:PSM (4:1) 
(B) vesicles by wild-type StnII (red) or its A10P (black), R29Q (light blue), R51Q (dark 
blue), F106L (magenta), Y111N (light green), Y135F (purple), Y136F (dark green), and 
G142A (gray) mutants. Calcein-entrapped vesicles were prepared with extrusion and 
release was measured at 23 °C. All intensities were normalized. Towards the end of the 
measurement (at 200 s in A and 800 s in B), Triton X-100 was added to dissolve the LUVs 
and release all calcein. The results shown are representative of two different  
independent experiments. 
3. Discussion 
Pore formation by actinoporins is the result of a series of well coordinated events. The recently 
refined model of this mechanism [37,39,40] predicts that, after an extremely fast toxin binding to the 
membrane, major conformational changes occur, resulting in the simultaneous presence of several 
distinct membrane-bound protein forms (Figure 5). These conformational changes involve  
long-distance rearrangements [47,48] which complicate the interpretation of the effects produced by 
individual mutations, especially if these changes affect the protein face involved in recognizing the 
membrane. According to the mentioned mechanism, one of the first distinct conformational species to 
appear would be represented by a molecule in which an extended N-terminal α1 helix would lie more 
or less parallel to the membrane surface [49]. Then, this elongated α1 helix would be inserted into the 
membrane, a step which would be faster than the oligomerization step [37]. Finally, functional pore 
formation would take place as the result of a mechanism which begins with the formation of dimers 
and ends in a toroidal protein-lipid structure (Figure 5) lacking a well-defined fixed  
stoichiometry [17,38–40]. A stable prepore structure is not required according to this model, in clear 
contrast to β-pore forming toxin behavior [50,51]. However, an alternative non-toroidal nonameric pore 
based on a detergent-containing crystalline structure, has been also proposed for the actinoporin  
Fra C [41]. Independently of the pore formation mechanism, it is well-established that Chol enhances 
pore formation by actinoporins not only because induces the formation of raft-like domains but also 
because, even at low concentrations, it still affects the physical state of SM [21,22,26–29]. The results 
Calcein release 
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presented here reveal the influence of this lipid on the essential long-distance rearrangements required 
for pore-formation, since the StnII variants that were studied harbor mutations that affect residues in 
protein regions with assigned key roles in pore formation (Figures 1 and 5). 
 
Figure 5. Illustration representing the pore-forming mechanism of actinoporins. Once the 
protein is attached to the membrane, the N-terminal α1 helix extends and inserts into the 
bilayer. Finally, oligomerization conduces to a final toroidal pore. The blue shape represents 
the β-sandwich core. The green dots represent the 30 first residues before and after the 
extension of the α1 helix extension. Red dots represent the approximate location of the 
residues mutated in the work presented here. This figure has been adapted from [37]. 
3.1. StnII Mutants Affecting the 30 First Residues Sequence Stretch 
StnII Ala10 is located at the edge of the region thought to become α-helical to form the pore [49]. 
Thus, StnII A10P contains a mutation which is located far away from the membrane binding surface 
(Figures 1 and 5) and therefore does not participate directly in the long-distance rearrangements 
needed for membrane recognition. This mutation has been shown to provide enough conformational 
stiffness so as to hamper the required α1 helix extension [29,42,52] (Figure 5). This is in good 
agreement with the behavior of a double cysteine mutant of EqtII, which was also designed to increase 
the stiffness of this protein region [53]. It was then proposed that neither the presence of the N-
terminal stretch region nor the conformational changes occurring along this sequence after membrane 
binding would provide higher affinity of StnII for the bilayer. Binding of A10P was not substantially 
affected by the presence or absence of Chol. However, hemolysis and calcein leakage activity in the 
absence of Chol were clearly diminished (Tables 1 and 2; Figure 4B), thus suggesting that pore 
formation, but not membrane recognition, is impaired in this mutant. On the other hand, like the  
wild-type protein, A10P was observed to bind with greater affinity to Chol-containing lipid vesicles 
(Tables 1 and 2), which explains the differences observed between both types of vesicles in terms of 
calcein leakage. Thus, A10P could be considered a reference for efficient protein binding without pore 
formation. The presence of Chol (Figure 4A) allows leakage of water soluble solutes even in the 
absence of a completely extended N-terminal α-helix, a result that would reinforce the hypothesis in 
favor of the toroidal nature of the pore [17,38,39]. 
The other residue mutated along this polypeptide region, Arg29, is a conserved amino acid [11] 
located at the C-terminal end of this 30 residues long protein stretch (Figure 1). This residue has been 
shown to be crucial because of its involvement in membrane recognition and also in sustaining the 
Mechanism of pore formation 
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necessary conformational changes leading to pore formation [29]. A rotation between StnII Ser28 and 
Arg29 might occur after membrane binding [34], inducing these conformational changes. In addition, 
Arg29 and Phe106 establish a cation-π interaction, which is needed to provide the protein with the 
right conformational flexibility [42]. This interaction is not possible in the R29Q mutant, which results 
in an increased conformational freedom of this region that, in turn, greatly distorts the distribution of 
the electrostatic potential along the surface of the protein face involved in recognizing the membrane [47]. 
Relative membrane binding affinity for the DOPC:SM:Chol (1:1:1) was greatly diminished (Table 2; 
Figure 2), in agreement with less hemolytic (Table 1) and calcein release activities, (Figure 4). In the 
absence of Chol, binding and calcein leakage were not detectable (Figures 3 and 4B). Altogether, these 
results reveal a key role for Chol in the correct binding and positioning of the region around StnII 
Arg29 on the membrane in order to produce a functional pore. 
3.2. StnII Mutants Affecting the Aromatic Cluster 
The mutations affecting the aromatic cluster of StnII were F106L, Y111N, Y135F, and Y136F. 
NMR analysis of the aromatic resonances of the equivalent StnI groups in the presence of 
dodecylphosphocholine micelles revealed a high motional flexibility of StnI Tyr-136 and Tyr-137  
(Tyr 135 and 136 in StnII) [54]. From this point of view, given that the hydrophobicity of the side 
chain of these two residues is maintained in the mutants, it can be explained why they still interact 
fairly well with the Chol containing vesicles (Figures 2 and 4A) while they are completely unable to 
maintain the specific contacts in the absence of Chol (Figures 3 and 4B; see also below). Interestingly, 
StnITyr-112 (Tyr111 in StnII) was not affected by the micellar media [54]. Detailed inspection of the 
water soluble forms of EqtII and StnII reveals that the loop containing this residue (segment spanning 
StnII Tyr108 to Tyr111) is completely disordered and displays high conformational flexibility [34,35,55]. 
In the crystal structure of the StnII:POC complex [34], the aromatic ring of Tyr111 is pointing towards 
the POC moiety after a probable conformational change from its exposed POC-free state [54]. Indeed, 
it has also been proposed that Tyr111 would induce a necessary disorder in exposed hydrophobic 
chains to promote their interaction with the membrane [47]. Finally, as stated above, Phe106 and 
Arg29 establish an interaction which may function like a switch to turn on the conformational changes 
needed for protein binding to the membrane [42,47]. 
Taking all this into account, the results presented here agree with the existence of the 
aforementioned network of long-range interactions, given that any of the single mutations studied 
rendered protein variants completely unable to interact with the POPC:PSM (4:1) vesicles (Figures 3 
and 4). This situation changed significantly in the presence of Chol (Figures 2 and 4) since some of the 
residues involved are also part of the POC-binding site, as explained below. 
3.3. StnII Mutants Affecting the POC-Binding Site 
The StnII mutants affecting the POC-binding site studied herein were R51Q, Y111N, Y135F, and 
Y136F. Three of these mutated amino acids are involved in the aromatic cluster, and all four 
participate in specific interactions with the POC moiety and/or the 2NH and 3OH groups of  
SM [24,29,34,41,42,47,54,56]. Therefore, these four mutants displayed diminished hemolytic activities 
(Table 1) and lacked the ability to interact with PSM containing vesicles in the absence of Chol  
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(Table 2; Figures 3 and 4). However, they behave differently when studied against DOPC:SM:Chol 
(1:1:1) vesicles (Table 2; Figures 3 and 4) and could be ascribed to three different behavior patterns. 
First, in the presence of Chol, Y136F was quite similar to the wild-type StnII in terms of membrane 
affinity (Figure 2) and calcein release activity (Figure 4A) but was not able to interact with the 
POPC:PSM (4:1) vesicles (Figure 3). These results agree with the role assigned to Tyr136 in 
interacting specifically with the phosphate oxygens of the POC moiety [24], contributing to its 
stabilization within the POC-binding pocket. In the absence of Chol, this interaction would then be 
essential for maintaining the SM molecule at the right position, and therefore this mutant failed in 
binding efficiently enough to the vesicles. 
The second pattern would correspond to the Y135F mutant. Tyr135 is a residue which has been 
related to interactions with the SM 2NH and 3OH groups through the phenolic hydroxyl group [24]. 
Both interactions would be absent in the mutant assayed. This would explain the obtained results in 
terms of lower hemolytic activity (Table 1) and much lower relative membrane binding affinity 
(Table 2) as well as the dampened calcein release properties (Figure 4A) against DOPC:SM:Chol 
(1:1:1) vesicles. However, this mutant was completely unable to bind to the POPC:PSM (4:1) vesicles, 
and therefore it can be inferred that the interactions with the SM molecule involving Tyr135 are 
enhanced in the presence of Chol. 
Regarding the third pattern, the last two mutants studied, R51Q and Y111N, displayed quite low 
hemolytic activity (especially Y111N) and a rather low affinity for both types of vesicles studied 
(Table 2).They were also completely inactive in the calcein release experiments (Figure 4). It has been 
proposed that the POC phosphate moiety could be further stabilized by the cationic side chain of 
Arg51 [24]. Thus, these results would also support the abovementioned role of Tyr111 in the observed 
conformational change from its exposed free state to the POC-bound complex [34]. The Y111N 
mutant would not be able to provide the required interactions and therefore would fail to produce a 
functional pore even in the presence of Chol (Figure 4A). Finally, according to the present results, it 
can also be stated that the interaction provided by the side chain of StnII Arg51 is strictly required for 
membrane recognition independently of Chol. 
3.4. StnII Mutant Affecting the Pore-Competent State of Protein Oligomerization 
StnII Gly142 belongs to a conserved RGD motif which has been related to maintaining the protein 
in the correct aggregation competent state, not only in its water-soluble state, but also in its membrane 
bound configuration [43]. Therefore, it would not be a residue directly involved in membrane 
recognition, nor in pore formation (Figure 1). In good agreement with this hypothesis, in the presence 
of Chol, both the G142A mutant and the wild-type protein showed similar behaviors in terms of 
membrane binding (Table 2; Figure 2) and calcein release activity (Figure 4A). However, this mutant 
failed to bind to the POPC:PSM (4:1) vesicles (Figure 3). Inspection of the relative orientation of 
Gly142 within the StnII three-dimensional structure (Figures 1 and 6) suggests how this residue could 
also be involved in the required long-distance rearrangements [47,48] for its correct attachment to the 
membrane. The presence of an additional obstructing methyl group in the G142A mutant would distort 
not only a well-established ionic interaction between Arg141 and Asp143, but also the stabilization of 
Gly142 by the hydroxyl group of Ser163 (Figure 6). Mutation to Ala would then interfere with these 
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rearrangements, leading to a more aggregation-prone protein that is nonetheless unable to bind to the 
membrane in a pore-competent state. This effect would be especially evident in the absence of Chol. 
 
Figure 6. Close-up diagram representation of the residues presumably affected by 
substitution of StnII Gly142 (red) by an Ala residue: Ser112 (blue), Arg141 (green), 
Asp143 (green), and Ser163 (blue). Image was generated by the MolMol Program [67]. 
4. Experimental Section 
4.1. Materials 
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC), cholesterol (Chol), and porcine brain sphingomyelin (SM) were obtained from Avanti Polar 
Lipids. Palmitoyl-SM (PSM) was purified from egg SM using preparative HPLC on a reverse phase 
(C18) column, as described previously [58,59]. Calcein was from Fluka/Sigma-Aldrich (St. Louis, MO 
63103, USA). Sephacryl S200HR was obtained from GE Healthcare. The cDNA coding for the StnII 
mutants were obtained by the overlap extension mutagenesis method [60], also as described [61].  
Wild-type StnII and all the mutants used in this study were produced in an E. coli expression system, 
and purified as described previously [29,42,61].The homogeneity of all protein samples used was 
analyzed by SDS/PAGE and amino acid analysis after acid hydrolysis of the proteins (5.7 M HCl, 
24 h, 110 °C). These amino acid analyses were performed on a Biochrom 20 automatic analyzer 
(Pharmacia, Cambridge, UK). 
4.2. Spectroscopic Characterization 
Spectroscopic characterization was essentially performed as previously described [29,43,48,62–64]. 
Absorbance measurements were carried out on a Uvikon 930 spectrophotometer (Kontron Instruments, 
Madrid, Spain). The individual E0.1% (280 nm, 1 cm) coefficients were calculated for every single 
protein species as described [21,29,43], using their amino acid compositions and specific  
Location of Gly142 
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UV-absorption spectra [9,21,65]. Far-UV circular dichroism (CD) spectra were obtained on a Jasco 
715 spectropolarimeter at50 nm/min scanning speed. Optical path cells of 0.1 cm were employed. 
Proteins were dissolved in 15 mM MOPS buffer, pH 7.5, containing 100 mM NaCl (0.2 mg/mL 
protein concentration). At least four spectra were averaged to obtain the final spectrum. CD 
measurements were also employed to study the thermal stability of the mutants, as described  
before [29,48,62]. Tm values correspond to the temperature at the midpoint of the monophasic thermal 
denaturation transition. 
4.3. Hemolysis Assay 
Hemolysis assays were performed in 96-multiwell plates as previously described [29,61]. Briefly, 
erythrocytes from heparinized sheep blood were washed in 10 mM Tris buffer, pH 7.4, containing 0.145 M 
NaCl, to a final OD655 of 0.5 when mixing equal volumes of the cell suspension and buffer. The 
hemolysis was followed as a decrease in OD655 after addition of the erythrocyte suspension to twofold 
serial dilutions of the proteins. An Expert 96 microplate reader (AsysHitech, GmbH, Eugendorf, 
Austria) was employed to measure OD655. The value obtained with 0.1% (w/v) Na2CO3 was 
considered 100% hemolysis. HC50 is the protein concentration required to produce 50% hemolysis. 
4.4. Binding of StnII to Bilayer Membranes 
Binding was measured using isothermal titration calorimetry (ITC) as described before [24,29,43], 
using a VP-ITC calorimeter (MicroCal). Briefly, protein solutions at 10 μM were titrated by injection 
of 20 μL aliquots of lipid suspensions (phospholipid concentration: 5 mM). Binding isotherms were 
adjusted to a model were the protein binds the membrane involving “n” lipid molecules [29]. 
4.5. Calcein Leakage Assay 
Calcein-entrapped POPC:PSM (4:1) or DOPC:SM:Chol (1:1:1) large unilamellar vesicles (LUVs) 
were prepared as described [27] by extrusion through 200 nm filters (Nucleopore, Whatman) at 37 °C, 
or 60 °C if Chol was not present. Briefly, the desired lipids were mixed and dried under a stream of 
nitrogen. The lipids were re-dissolved in chloroform and dried again before removal of any traces of 
remaining solvent in vacuum for 60 min. Prior to extrusion, the dry lipid films were hydrated for 
30 min at 60 °C (or 37 °C if Chol was present) in Tris buffer (10 mM Tris, 140 mM NaCl, pH 7.4) 
containing calcein at a concentration of 100 mM. The total lipid concentration was 1.25 mM. LUVs 
were separated from non-entrapped calcein by gel filtration on Sephacryl S200HR. These LUVs were used 
for permeabilization studies within 24 h. Phospholipid concentration was determined from Pi 
measurement [66] after elution of vesicles during isolation. The concentration of LUV phospholipids 
and StnII during calcein leakage experiments were about 7.5 μM and 20 nM, respectively. Emission at 
550 nm was followed at 23 °C as a function of time (excitation at 480 nm). Fluorescence emission was 
measured with a PTI Quanta-Master spectrofluorimeter (Photon Technology International, Inc., 
Edison, New Jersey, USA). To ensure that no major spontaneous leakage occurred, the emission was 
measured for each sample during 5 min before addition of toxin. A steady signal level, indicating 
intact vesicles, was observed for all samples. 
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5. Conclusions 
One major conclusion of the results presented here is that Chol is a key molecule in the correct and 
efficient interaction of StnII with its target membranes in order to produce a functional pore. It is now 
proven that this lipid molecule is even able to circumvent the impairment produced by the substitution 
of residues specifically involved in SM recognition and/or membrane surface attachment. Thus, 
although SM would definitively be the crucial molecule for specific membrane recognition, Chol 
would also act as a highly important partner in this interaction. At the temperatures employed in  
these experiments, POPC:SM (4:1) bilayers exist in a liquid disordered phase. However, the 
DOPC:SM:Chol vesicles employed display liquid disordered-liquid ordered phase coexistence and 
have domain boundaries. Therefore, the observed effects of Chol could be due not only to the reported 
specific influence on the SM physical state [27] but also to coexistence of different phases on the 
membrane. Similar effects have been reported already, if not for attachment, at least for the final 
formation of the pore [21,25,29,57]. 
It has been previously acknowledged that a series of conformational changes involving  
long-distance rearrangements of the residues on the protein side facing the membrane must occur for 
the correct attachment of StnII to the membrane surface. Substitution of individual residues involved in 
these rearrangements has a dramatic impact on the interaction of StnII with PSM containing vesicles in 
the absence of Chol, but the impact of these mutations is nearly negligible if Chol is present. 
Therefore, it can also be concluded that the presence of Chol would ease the requirements needed for 
these conformational rearrangements to occur. 
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